Skip to content

Evaluation of Trigeminal Nerve Blockade

Evaluation of Trigeminal Nerve Blockade in the Pterygopalatine Fossa for Cleft Palate Repair: a Pilot Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03632044
Enrollment
40
Registered
2018-08-15
Start date
2018-11-20
Completion date
2027-10-30
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Birth Defect, Cleft Palate, Mouth Abnormalities

Brief summary

Cleft palate repair requires high doses of opioids for pain control postop. An alternative approach is placement of nerve blocks in the pterygopalatine fossa bilaterally, blocking the maxillary nerve & covering the entire midface. Application of bilateral suprazygomatic maxillary nerve blockade of the infraorbital nerve may provide effective analgesia for cleft lip repair, improving time to oral intake, pain control and time to hospital discharge.

Detailed description

Cleft palate is a common congenital anomaly for which surgical repair is indicated during early childhood. The surgical repair of cleft palate is very painful, and generally requires high doses of opioids for adequate pain control, placing children at risk for post-operative respiratory depression and airway obstruction. An alternative approach to post-operative analgesia for cleft palate repair is the placement of nerve blocks in the pterygopalatine fossa bilaterally, blocking the maxillary nerve and covering the entire mid-face. This randomized, double-blinded study will investigate the utility of maxillary nerve blockade in controlling post-operative pain, decreasing opioid requirements, improving post-operative oral food and drink intake, and decreasing hospital length-of-stay after cleft palate repair.

Interventions

DRUGRopivacaine

A single injection into the pterygopalatine fossa bilaterally of 0.2% ropivacaine at a dose of 0.15 mL/kg (block) after the induction of general anesthesia

OTHERSham Comparator

The subcutaneous placement of a 25 Gauge needle as a sham control after the induction of general anesthesia. Nothing will be injected.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

During the block placement the surgical team will be asked to leave the operating room briefly to remain blinded to the group assignment of all patients as the surgical team will manage the subjects post-operative care and determine discharge readiness. ICU nursing staff and parents will be informed of participation in the study but will not be informed as to group assignment to remain blinded.

Intervention model description

This randomized, double-blinded study. Subjects will be randomly assigned to one of two different protocols by a designated study team member based on a computer generated randomization table. Randomization will occur following consent. Randomization will be 1:1.

Eligibility

Sex/Gender
ALL
Age
3 Months to 5 Years
Healthy volunteers
No

Inclusion criteria

* Patient presenting for palatoplasty for cleft palate only. * Parent/guardian consents to participate * Normal oral food and water intake before surgery * No underlying chronic pain condition

Exclusion criteria

* Parent/guardian refuses to consent * Patient requires revision surgery on the palate * Patient requires surgery in addition to palatoplasty, including, but not limited to pharyngeal flap or soft palate lengthening procedures. * Any underlying chronic pain condition * Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for block placement. * Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for research participation. * History of Pierre Robin sequence * Planned or anticipated need for any type of artificial airway post-op

Design outcomes

Primary

MeasureTime frameDescription
Change in time to oral intake following palatoplasty for cleft palateChange from baseline (post-op) and through study completion, an average of 96 hours.Application of bilateral suprazygomatic maxillary nerve blockade of the infraorbital nerve to provide effective analgesia for cleft lip repair, improving time to oral intake after surgery.

Secondary

MeasureTime frameDescription
Change in amount of opioids following palatoplasty for cleft palateChange from baseline (post-op) and through study completion, an average of 96 hours.Application of bilateral suprazygomatic maxillary nerve blockade of the infraorbital nerve to provide effective analgesia for cleft lip repair, improving pain control after surgery.
Change in length of hospitalization following palatoplasty for cleft palateChange from baseline (post-op) and through study completion, an average of 96 hours.Application of bilateral suprazygomatic maxillary nerve blockade of the infraorbital nerve to provide effective analgesia for cleft lip repair, improving time to hospital discharge after surgery.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCameron R Smith, MD, PhD

University of Florida

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026